Stephanie Hollis Clinical Oncology Society of Australia Annual Scientific Meeting 2019

Abstracts this author is presenting:

• SOLACE2: A phase II randomised trial of immune priming by olaparib-cyclophosphamide prior to olaparib-durvalumab in asymptomatic, platinum-sensitive recurrent ovarian cancer — Poster Session 1